# PROCARES (Harbinger Health diagnostic aid in people with suspected cancer)

Source: https://onco.cc/trials/procares/  
OnCo record `procares` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Harbinger Health's study of whether its blood tests can help sort out which people with worrying symptoms have cancer.

## Summary

PROCARES (NCT07046260) is an observational study sponsored by Harbinger Health. Its primary objective is to establish the performance of two blood-based diagnostic-aid tests for cancer detection in people presenting with symptoms, signs or findings suggestive of cancer.

The registry record, read on 29 October 2026, gives its status as recruiting, with an estimated 2,450 participants, a start on 11 July 2025 and primary completion expected in November 2026.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-10-29
- Also known as: PROCARES
- Registry id: NCT07046260
- Phase: observational
- Setting: People in the United States with symptoms, signs or findings suggestive of cancer, with case enrichment, giving blood to test two diagnostic-aid blood tests
- Sponsor: Harbinger Health
- Enrolled: 2450

## Sources

- ClinicalTrials.gov NCT07046260: https://clinicaltrials.gov/study/NCT07046260

## Connected records

- trials: [CORE-HH (Harbinger Health test development and validation)](https://onco.cc/trials/core-hh/)
- fronts: [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- drugs: [RESOLVE (Harbinger Health)](https://onco.cc/drugs/harbinger-resolve/)
- companies: [Harbinger Health](https://onco.cc/companies/harbinger-health/)

---
JSON: https://onco.cc/api/v1/entities/procares.json